Lundbeck cuts jobs and pipeline but at least the money's all right - for now
This article was originally published in Scrip
Executive Summary
Lundbeck has announced plans to cut up to 175 jobs in Denmark and the US (12.5% of 1.400 its R&D employees) as it seeks to outsource more R&D work. At the same time, it removed four programmes from its clinical development pipeline.